nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGA2B—endothelium—glaucoma	0.0621	0.437	CbGeAlD
Tirofiban—ITGB3—endothelium—glaucoma	0.0543	0.382	CbGeAlD
Tirofiban—ITGB3—Molecules associated with elastic fibres—LTBP3—glaucoma	0.0261	0.0496	CbGpPWpGaD
Tirofiban—ITGB3—Molecules associated with elastic fibres—LTBP2—glaucoma	0.0261	0.0496	CbGpPWpGaD
Tirofiban—ITGB3—connective tissue—glaucoma	0.0257	0.181	CbGeAlD
Tirofiban—ITGB3—Elastic fibre formation—LTBP2—glaucoma	0.0203	0.0386	CbGpPWpGaD
Tirofiban—ITGB3—Elastic fibre formation—LTBP3—glaucoma	0.0203	0.0386	CbGpPWpGaD
Tirofiban—ITGA2B—Ephrin B reverse signaling—NCK2—glaucoma	0.016	0.0304	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—LMX1B—glaucoma	0.0129	0.0246	CbGpPWpGaD
Tirofiban—ITGB3—Elastic fibre formation—LOXL1—glaucoma	0.0125	0.0239	CbGpPWpGaD
Tirofiban—ITGB3—Ephrin B reverse signaling—NCK2—glaucoma	0.0123	0.0234	CbGpPWpGaD
Tirofiban—Haemorrhage intracranial—Pilocarpine—glaucoma	0.011	0.033	CcSEcCtD
Tirofiban—ITGB3—Elastic fibre formation—ELN—glaucoma	0.011	0.0209	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—COL11A1—glaucoma	0.00972	0.0185	CbGpPWpGaD
Tirofiban—Bradycardia—Physostigmine—glaucoma	0.00959	0.0288	CcSEcCtD
Tirofiban—ITGA2B—GRB2:SOS provides linkage to MAPK signaling for Integrins—FN1—glaucoma	0.00836	0.0159	CbGpPWpGaD
Tirofiban—ITGA2B—p130Cas linkage to MAPK signaling for integrins—FN1—glaucoma	0.00836	0.0159	CbGpPWpGaD
Tirofiban—ITGB3—Monoamine Transport—SLC6A1—glaucoma	0.00817	0.0155	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—TXN—glaucoma	0.00806	0.0153	CbGpPWpGaD
Tirofiban—ITGB3—Molecules associated with elastic fibres—TGFB2—glaucoma	0.00701	0.0133	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—CAV2—glaucoma	0.00661	0.0126	CbGpPWpGaD
Tirofiban—ITGB3—p130Cas linkage to MAPK signaling for integrins—FN1—glaucoma	0.00644	0.0122	CbGpPWpGaD
Tirofiban—ITGB3—GRB2:SOS provides linkage to MAPK signaling for Integrins—FN1—glaucoma	0.00644	0.0122	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—TXN—glaucoma	0.00621	0.0118	CbGpPWpGaD
Tirofiban—Hypertension—Dipivefrin—glaucoma	0.00602	0.0181	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Bimatoprost—glaucoma	0.00596	0.0179	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—LTBP2—glaucoma	0.00594	0.0113	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—LTBP3—glaucoma	0.00594	0.0113	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—NCK2—glaucoma	0.00571	0.0109	CbGpPWpGaD
Tirofiban—ITGA2B—ECM proteoglycans—TGFB2—glaucoma	0.0056	0.0107	CbGpPWpGaD
Tirofiban—ITGB3—Elastic fibre formation—TGFB2—glaucoma	0.00546	0.0104	CbGpPWpGaD
Tirofiban—Hypercholesterolaemia—Brimonidine—glaucoma	0.00528	0.0159	CcSEcCtD
Tirofiban—ITGA2B—Integrin alphaIIb beta3 signaling—FN1—glaucoma	0.00522	0.00994	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—COL11A1—glaucoma	0.00522	0.00993	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—CAV2—glaucoma	0.00509	0.00969	CbGpPWpGaD
Tirofiban—Hypercholesterolaemia—Travoprost—glaucoma	0.00502	0.0151	CcSEcCtD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—IL1A—glaucoma	0.00494	0.0094	CbGpPWpGaD
Tirofiban—Myocardial infarction—Metipranolol—glaucoma	0.00492	0.0148	CcSEcCtD
Tirofiban—Pain—Dipivefrin—glaucoma	0.00487	0.0146	CcSEcCtD
Tirofiban—ITGB3—Osteopontin Signaling—MMP9—glaucoma	0.0046	0.00875	CbGpPWpGaD
Tirofiban—Bradycardia—Metipranolol—glaucoma	0.00458	0.0138	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—LTBP3—glaucoma	0.00458	0.00871	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—LTBP2—glaucoma	0.00458	0.00871	CbGpPWpGaD
Tirofiban—ITGB3—ECM proteoglycans—TGFB2—glaucoma	0.00432	0.00821	CbGpPWpGaD
Tirofiban—Sweating—Carbachol—glaucoma	0.00427	0.0129	CcSEcCtD
Tirofiban—Bradycardia—Carteolol—glaucoma	0.00425	0.0128	CcSEcCtD
Tirofiban—Hypersensitivity—Dipivefrin—glaucoma	0.00419	0.0126	CcSEcCtD
Tirofiban—ITGA2B—Platelet degranulation—TGFB2—glaucoma	0.00415	0.0079	CbGpPWpGaD
Tirofiban—Swelling—Brimonidine—glaucoma	0.00411	0.0124	CcSEcCtD
Tirofiban—Pain—Echothiophate—glaucoma	0.00408	0.0123	CcSEcCtD
Tirofiban—ITGA2B—Platelet Aggregation (Plug Formation)—FN1—glaucoma	0.00406	0.00772	CbGpPWpGaD
Tirofiban—ITGB3—Integrin alphaIIb beta3 signaling—FN1—glaucoma	0.00402	0.00765	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—COL11A1—glaucoma	0.00402	0.00765	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—COL11A1—glaucoma	0.00401	0.00764	CbGpPWpGaD
Tirofiban—Bradycardia—Levobunolol—glaucoma	0.00401	0.0121	CcSEcCtD
Tirofiban—Haematuria—Methazolamide—glaucoma	0.00401	0.0121	CcSEcCtD
Tirofiban—Nausea—Physostigmine—glaucoma	0.00397	0.012	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—NCK2—glaucoma	0.00397	0.00756	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—CAV2—glaucoma	0.00396	0.00753	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.00395	0.00753	CbGpPWpGaD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—IL1A—glaucoma	0.00381	0.00724	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—NCK2—glaucoma	0.00375	0.00714	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—LOXL1—glaucoma	0.00367	0.00698	CbGpPWpGaD
Tirofiban—ITGA2B—Beta3 integrin cell surface interactions—FN1—glaucoma	0.0036	0.00685	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—MYLK—glaucoma	0.00355	0.00675	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—NCK2—glaucoma	0.00351	0.00668	CbGpPWpGaD
Tirofiban—Hypertension—Metipranolol—glaucoma	0.00338	0.0102	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Betaxolol—glaucoma	0.00331	0.00996	CcSEcCtD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—CAV1—glaucoma	0.00325	0.00618	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—ELN—glaucoma	0.00321	0.0061	CbGpPWpGaD
Tirofiban—Oedema—Metipranolol—glaucoma	0.0032	0.00962	CcSEcCtD
Tirofiban—ITGB3—Platelet degranulation—TGFB2—glaucoma	0.0032	0.00609	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—SOD1—glaucoma	0.00315	0.00599	CbGpPWpGaD
Tirofiban—ITGB3—Platelet Aggregation (Plug Formation)—FN1—glaucoma	0.00313	0.00595	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—COL11A1—glaucoma	0.00309	0.00588	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin-mediated events—MMP2—glaucoma	0.00305	0.00581	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—CAV2—glaucoma	0.00305	0.0058	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.00305	0.0058	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.003	0.0057	CbGpPWpGaD
Tirofiban—Bradycardia—Apraclonidine—glaucoma	0.00297	0.00895	CcSEcCtD
Tirofiban—Oedema—Carteolol—glaucoma	0.00296	0.00891	CcSEcCtD
Tirofiban—Haemorrhage—Apraclonidine—glaucoma	0.00292	0.00879	CcSEcCtD
Tirofiban—Thrombocytopenia—Diclofenamide—glaucoma	0.00285	0.00858	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—LOXL1—glaucoma	0.00283	0.00538	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FN1—glaucoma	0.00282	0.00537	CbGpPWpGaD
Tirofiban—Haematuria—Acetazolamide—glaucoma	0.00278	0.00835	CcSEcCtD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—FN1—glaucoma	0.00277	0.00527	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Carbachol—glaucoma	0.00275	0.00827	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—MYLK—glaucoma	0.00273	0.0052	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Methazolamide—glaucoma	0.00268	0.00807	CcSEcCtD
Tirofiban—Myocardial infarction—Dorzolamide—glaucoma	0.00262	0.00787	CcSEcCtD
Tirofiban—Oedema—Latanoprost—glaucoma	0.0026	0.00781	CcSEcCtD
Tirofiban—Sweating—Dorzolamide—glaucoma	0.00256	0.00769	CcSEcCtD
Tirofiban—ITGA2B—Integrin cell surface interactions—FN1—glaucoma	0.00255	0.00486	CbGpPWpGaD
Tirofiban—Bradycardia—Brimonidine—glaucoma	0.00255	0.00768	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—CAV1—glaucoma	0.0025	0.00476	CbGpPWpGaD
Tirofiban—Myocardial infarction—Pilocarpine—glaucoma	0.00247	0.00743	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—ELN—glaucoma	0.00247	0.0047	CbGpPWpGaD
Tirofiban—Bradycardia—Dorzolamide—glaucoma	0.00244	0.00733	CcSEcCtD
Tirofiban—Pain—Carbachol—glaucoma	0.00243	0.00731	CcSEcCtD
Tirofiban—Bradycardia—Travoprost—glaucoma	0.00243	0.0073	CcSEcCtD
Tirofiban—ITGB3—Platelet degranulation—SOD1—glaucoma	0.00242	0.00461	CbGpPWpGaD
Tirofiban—Sweating—Pilocarpine—glaucoma	0.00242	0.00727	CcSEcCtD
Tirofiban—Haematuria—Pilocarpine—glaucoma	0.0024	0.00723	CcSEcCtD
Tirofiban—Bradycardia—Brinzolamide—glaucoma	0.0024	0.00721	CcSEcCtD
Tirofiban—Pain—Levobunolol—glaucoma	0.00239	0.0072	CcSEcCtD
Tirofiban—Hypersensitivity—Metipranolol—glaucoma	0.00236	0.00709	CcSEcCtD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.00231	0.00439	CbGpPWpGaD
Tirofiban—Bradycardia—Pilocarpine—glaucoma	0.0023	0.00693	CcSEcCtD
Tirofiban—Body temperature increased—Diclofenamide—glaucoma	0.0023	0.00693	CcSEcCtD
Tirofiban—ITGB3—Osteopontin-mediated events—MMP9—glaucoma	0.0023	0.00437	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—BCL2L1—glaucoma	0.00226	0.00429	CbGpPWpGaD
Tirofiban—Body temperature increased—Carbachol—glaucoma	0.00225	0.00676	CcSEcCtD
Tirofiban—Urticaria—Levobunolol—glaucoma	0.00222	0.00669	CcSEcCtD
Tirofiban—Pain—Latanoprost—glaucoma	0.00222	0.00668	CcSEcCtD
Tirofiban—ITGA2B—Platelet degranulation—FN1—glaucoma	0.00219	0.00417	CbGpPWpGaD
Tirofiban—Hypersensitivity—Carteolol—glaucoma	0.00218	0.00657	CcSEcCtD
Tirofiban—Urticaria—Methazolamide—glaucoma	0.00213	0.00641	CcSEcCtD
Tirofiban—Hypertension—Bimatoprost—glaucoma	0.00213	0.0064	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—NCK2—glaucoma	0.00213	0.00405	CbGpPWpGaD
Tirofiban—Body temperature increased—Methazolamide—glaucoma	0.00212	0.00638	CcSEcCtD
Tirofiban—Dizziness—Metipranolol—glaucoma	0.00211	0.00636	CcSEcCtD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.00209	0.00397	CbGpPWpGaD
Tirofiban—Oedema—Apraclonidine—glaucoma	0.00208	0.00624	CcSEcCtD
Tirofiban—Hypersensitivity—Levobunolol—glaucoma	0.00206	0.0062	CcSEcCtD
Tirofiban—ITGA2B—Beta3 integrin cell surface interactions—VEGFA—glaucoma	0.00206	0.00392	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—FN1—glaucoma	0.00204	0.00389	CbGpPWpGaD
Tirofiban—Chills—Pilocarpine—glaucoma	0.00203	0.00611	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—CAV1—glaucoma	0.00202	0.00384	CbGpPWpGaD
Tirofiban—Headache—Metipranolol—glaucoma	0.002	0.00603	CcSEcCtD
Tirofiban—ITGB3—Integrin cell surface interactions—FN1—glaucoma	0.00197	0.00374	CbGpPWpGaD
Tirofiban—Dizziness—Carteolol—glaucoma	0.00196	0.00589	CcSEcCtD
Tirofiban—Sweating—Clonidine—glaucoma	0.00193	0.00581	CcSEcCtD
Tirofiban—Dizziness—Diclofenamide—glaucoma	0.00193	0.00579	CcSEcCtD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—CAV1—glaucoma	0.00192	0.00366	CbGpPWpGaD
Tirofiban—Nausea—Metipranolol—glaucoma	0.0019	0.00571	CcSEcCtD
Tirofiban—Hypertension—Brimonidine—glaucoma	0.00189	0.00567	CcSEcCtD
Tirofiban—Dizziness—Carbachol—glaucoma	0.00188	0.00565	CcSEcCtD
Tirofiban—Anaphylactic shock—Acetazolamide—glaucoma	0.00186	0.00558	CcSEcCtD
Tirofiban—Headache—Carteolol—glaucoma	0.00186	0.00558	CcSEcCtD
Tirofiban—Dizziness—Levobunolol—glaucoma	0.00185	0.00557	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.00184	0.0035	CbGpPWpGaD
Tirofiban—Bradycardia—Clonidine—glaucoma	0.00184	0.00553	CcSEcCtD
Tirofiban—Headache—Diclofenamide—glaucoma	0.00182	0.00549	CcSEcCtD
Tirofiban—Thrombocytopenia—Acetazolamide—glaucoma	0.00182	0.00547	CcSEcCtD
Tirofiban—Hypertension—Dorzolamide—glaucoma	0.0018	0.00541	CcSEcCtD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—glaucoma	0.0018	0.00343	CbGpPWpGaD
Tirofiban—Hypertension—Travoprost—glaucoma	0.00179	0.00539	CcSEcCtD
Tirofiban—Oedema—Brimonidine—glaucoma	0.00178	0.00536	CcSEcCtD
Tirofiban—Headache—Carbachol—glaucoma	0.00178	0.00536	CcSEcCtD
Tirofiban—Pain—Apraclonidine—glaucoma	0.00177	0.00534	CcSEcCtD
Tirofiban—Hypertension—Brinzolamide—glaucoma	0.00177	0.00532	CcSEcCtD
Tirofiban—Nausea—Carteolol—glaucoma	0.00176	0.00529	CcSEcCtD
Tirofiban—Headache—Levobunolol—glaucoma	0.00175	0.00528	CcSEcCtD
Tirofiban—Nausea—Diclofenamide—glaucoma	0.00173	0.0052	CcSEcCtD
Tirofiban—ITGB3—Monoamine Transport—TNF—glaucoma	0.00172	0.00328	CbGpPWpGaD
Tirofiban—Pain—Bimatoprost—glaucoma	0.00172	0.00518	CcSEcCtD
Tirofiban—Myocardial infarction—Betaxolol—glaucoma	0.00172	0.00517	CcSEcCtD
Tirofiban—Dizziness—Latanoprost—glaucoma	0.00172	0.00516	CcSEcCtD
Tirofiban—Oedema—Dorzolamide—glaucoma	0.0017	0.00512	CcSEcCtD
Tirofiban—Anaphylactic shock—Dorzolamide—glaucoma	0.0017	0.00512	CcSEcCtD
Tirofiban—Hypertension—Pilocarpine—glaucoma	0.0017	0.00512	CcSEcCtD
Tirofiban—Oedema—Travoprost—glaucoma	0.00169	0.0051	CcSEcCtD
Tirofiban—Nausea—Carbachol—glaucoma	0.00169	0.00508	CcSEcCtD
Tirofiban—ITGB3—Platelet degranulation—FN1—glaucoma	0.00169	0.00321	CbGpPWpGaD
Tirofiban—Sweating—Betaxolol—glaucoma	0.00168	0.00505	CcSEcCtD
Tirofiban—Headache—Methazolamide—glaucoma	0.00168	0.00505	CcSEcCtD
Tirofiban—Nausea—Levobunolol—glaucoma	0.00166	0.005	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—CCND2—glaucoma	0.00166	0.00316	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Dorzolamide—glaucoma	0.00165	0.00495	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—NCK2—glaucoma	0.00164	0.00312	CbGpPWpGaD
Tirofiban—Headache—Latanoprost—glaucoma	0.00163	0.00489	CcSEcCtD
Tirofiban—Oedema—Pilocarpine—glaucoma	0.00161	0.00484	CcSEcCtD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.00161	0.00306	CbGpPWpGaD
Tirofiban—Bradycardia—Betaxolol—glaucoma	0.0016	0.00482	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—TGFB2—glaucoma	0.0016	0.00304	CbGpPWpGaD
Tirofiban—Nausea—Methazolamide—glaucoma	0.00159	0.00479	CcSEcCtD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—VEGFA—glaucoma	0.00159	0.00302	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Pilocarpine—glaucoma	0.00157	0.00474	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—MMP1—glaucoma	0.00156	0.00297	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Pilocarpine—glaucoma	0.00155	0.00468	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—CDKN2B—glaucoma	0.00154	0.00292	CbGpPWpGaD
Tirofiban—Hypersensitivity—Apraclonidine—glaucoma	0.00153	0.0046	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—glaucoma	0.00153	0.0029	CbGpPWpGaD
Tirofiban—Pain—Brimonidine—glaucoma	0.00152	0.00458	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—NCK2—glaucoma	0.00152	0.00289	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—CAV1—glaucoma	0.00149	0.00284	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—CAV1—glaucoma	0.00148	0.00282	CbGpPWpGaD
Tirofiban—Urticaria—Acetazolamide—glaucoma	0.00147	0.00444	CcSEcCtD
Tirofiban—Body temperature increased—Acetazolamide—glaucoma	0.00147	0.00441	CcSEcCtD
Tirofiban—Pain—Dorzolamide—glaucoma	0.00146	0.00438	CcSEcCtD
Tirofiban—Pain—Travoprost—glaucoma	0.00145	0.00436	CcSEcCtD
Tirofiban—Pain—Brinzolamide—glaucoma	0.00143	0.0043	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—FN1—glaucoma	0.00142	0.00271	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.00142	0.0027	CbGpPWpGaD
Tirofiban—Chills—Betaxolol—glaucoma	0.00141	0.00425	CcSEcCtD
Tirofiban—ITGB3—Integrins in angiogenesis—CDKN1B—glaucoma	0.00141	0.00267	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—CAV1—glaucoma	0.0014	0.00267	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.0014	0.00266	CbGpPWpGaD
Tirofiban—Pain—Pilocarpine—glaucoma	0.00138	0.00414	CcSEcCtD
Tirofiban—Sweating—Timolol—glaucoma	0.00137	0.00413	CcSEcCtD
Tirofiban—Dizziness—Apraclonidine—glaucoma	0.00137	0.00413	CcSEcCtD
Tirofiban—Urticaria—Dorzolamide—glaucoma	0.00135	0.00407	CcSEcCtD
Tirofiban—Body temperature increased—Dorzolamide—glaucoma	0.00135	0.00405	CcSEcCtD
Tirofiban—Dizziness—Bimatoprost—glaucoma	0.00133	0.004	CcSEcCtD
Tirofiban—Urticaria—Brinzolamide—glaucoma	0.00133	0.004	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—CAV1—glaucoma	0.00133	0.00252	CbGpPWpGaD
Tirofiban—Hypersensitivity—Brimonidine—glaucoma	0.00131	0.00395	CcSEcCtD
Tirofiban—Bradycardia—Timolol—glaucoma	0.00131	0.00394	CcSEcCtD
Tirofiban—Headache—Apraclonidine—glaucoma	0.0013	0.00391	CcSEcCtD
Tirofiban—Oedema—Clonidine—glaucoma	0.00128	0.00386	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—CCND2—glaucoma	0.00128	0.00244	CbGpPWpGaD
Tirofiban—Body temperature increased—Pilocarpine—glaucoma	0.00127	0.00382	CcSEcCtD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—CDKN1B—glaucoma	0.00126	0.0024	CbGpPWpGaD
Tirofiban—Headache—Bimatoprost—glaucoma	0.00126	0.00379	CcSEcCtD
Tirofiban—Thrombocytopenia—Clonidine—glaucoma	0.00126	0.00378	CcSEcCtD
Tirofiban—Hypersensitivity—Dorzolamide—glaucoma	0.00125	0.00377	CcSEcCtD
Tirofiban—ITGA2B—Platelet degranulation—VEGFA—glaucoma	0.00125	0.00238	CbGpPWpGaD
Tirofiban—Hypersensitivity—Travoprost—glaucoma	0.00125	0.00375	CcSEcCtD
Tirofiban—Hyperhidrosis—Clonidine—glaucoma	0.00124	0.00373	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MMP1—glaucoma	0.00124	0.00236	CbGpPWpGaD
Tirofiban—Nausea—Apraclonidine—glaucoma	0.00123	0.00371	CcSEcCtD
Tirofiban—Hypersensitivity—Brinzolamide—glaucoma	0.00123	0.00371	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—TGFB2—glaucoma	0.00123	0.00234	CbGpPWpGaD
Tirofiban—Dizziness—Acetazolamide—glaucoma	0.00123	0.00369	CcSEcCtD
Tirofiban—Nausea—Bimatoprost—glaucoma	0.0012	0.0036	CcSEcCtD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	0.00119	0.00227	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—CAV1—glaucoma	0.00119	0.00226	CbGpPWpGaD
Tirofiban—Hypersensitivity—Pilocarpine—glaucoma	0.00118	0.00356	CcSEcCtD
Tirofiban—Dizziness—Brimonidine—glaucoma	0.00118	0.00354	CcSEcCtD
Tirofiban—ITGB3—Integrins in angiogenesis—VEGFA—glaucoma	0.00117	0.00222	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—NCK2—glaucoma	0.00117	0.00222	CbGpPWpGaD
Tirofiban—Headache—Acetazolamide—glaucoma	0.00116	0.0035	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—CAV1—glaucoma	0.00115	0.00219	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—FN1—glaucoma	0.00113	0.00215	CbGpPWpGaD
Tirofiban—Dizziness—Dorzolamide—glaucoma	0.00113	0.00338	CcSEcCtD
Tirofiban—Dizziness—Travoprost—glaucoma	0.00112	0.00337	CcSEcCtD
Tirofiban—Oedema—Betaxolol—glaucoma	0.00112	0.00336	CcSEcCtD
Tirofiban—Headache—Brimonidine—glaucoma	0.00112	0.00336	CcSEcCtD
Tirofiban—Dizziness—Brinzolamide—glaucoma	0.00111	0.00333	CcSEcCtD
Tirofiban—Nausea—Acetazolamide—glaucoma	0.0011	0.00332	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—glaucoma	0.0011	0.00209	CbGpPWpGaD
Tirofiban—Pain—Clonidine—glaucoma	0.0011	0.0033	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—FN1—glaucoma	0.0011	0.00209	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Betaxolol—glaucoma	0.00109	0.00329	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—BAD—glaucoma	0.00108	0.00206	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Betaxolol—glaucoma	0.00108	0.00325	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.00108	0.00205	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—LRP12—glaucoma	0.00107	0.00203	CbGpPWpGaD
Tirofiban—Headache—Dorzolamide—glaucoma	0.00107	0.00321	CcSEcCtD
Tirofiban—Dizziness—Pilocarpine—glaucoma	0.00106	0.0032	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—NOS3—glaucoma	0.00106	0.00202	CbGpPWpGaD
Tirofiban—Headache—Travoprost—glaucoma	0.00106	0.00319	CcSEcCtD
Tirofiban—Nausea—Brimonidine—glaucoma	0.00106	0.00318	CcSEcCtD
Tirofiban—Headache—Brinzolamide—glaucoma	0.00105	0.00315	CcSEcCtD
Tirofiban—Urticaria—Clonidine—glaucoma	0.00102	0.00307	CcSEcCtD
Tirofiban—Body temperature increased—Clonidine—glaucoma	0.00102	0.00305	CcSEcCtD
Tirofiban—Nausea—Dorzolamide—glaucoma	0.00101	0.00304	CcSEcCtD
Tirofiban—Headache—Pilocarpine—glaucoma	0.00101	0.00303	CcSEcCtD
Tirofiban—Nausea—Travoprost—glaucoma	0.00101	0.00303	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—NOS3—glaucoma	0.001	0.00191	CbGpPWpGaD
Tirofiban—Nausea—Brinzolamide—glaucoma	0.000994	0.00299	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—PAX6—glaucoma	0.000982	0.00187	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—FN1—glaucoma	0.000971	0.00185	CbGpPWpGaD
Tirofiban—Hypertension—Timolol—glaucoma	0.000966	0.00291	CcSEcCtD
Tirofiban—ITGB3—Platelet degranulation—VEGFA—glaucoma	0.000965	0.00184	CbGpPWpGaD
Tirofiban—Pain—Betaxolol—glaucoma	0.000956	0.00288	CcSEcCtD
Tirofiban—Nausea—Pilocarpine—glaucoma	0.000955	0.00287	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—TGFB2—glaucoma	0.000949	0.00181	CbGpPWpGaD
Tirofiban—Hypersensitivity—Clonidine—glaucoma	0.000946	0.00285	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—MMP1—glaucoma	0.000923	0.00176	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	0.00092	0.00175	CbGpPWpGaD
Tirofiban—Oedema—Timolol—glaucoma	0.000913	0.00275	CcSEcCtD
Tirofiban—Anaphylactic shock—Timolol—glaucoma	0.000913	0.00275	CcSEcCtD
Tirofiban—Urticaria—Betaxolol—glaucoma	0.000888	0.00267	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—CAV1—glaucoma	0.000887	0.00169	CbGpPWpGaD
Tirofiban—Body temperature increased—Betaxolol—glaucoma	0.000884	0.00266	CcSEcCtD
Tirofiban—Hyperhidrosis—Timolol—glaucoma	0.000883	0.00266	CcSEcCtD
Tirofiban—Dizziness—Clonidine—glaucoma	0.000849	0.00255	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—FN1—glaucoma	0.000844	0.00161	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—FN1—glaucoma	0.000842	0.0016	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—BAD—glaucoma	0.000834	0.00159	CbGpPWpGaD
Tirofiban—Hypersensitivity—Betaxolol—glaucoma	0.000824	0.00248	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—LRP12—glaucoma	0.000822	0.00156	CbGpPWpGaD
Tirofiban—Headache—Clonidine—glaucoma	0.000804	0.00242	CcSEcCtD
Tirofiban—Pain—Timolol—glaucoma	0.000781	0.00235	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—VEGFA—glaucoma	0.000765	0.00146	CbGpPWpGaD
Tirofiban—Nausea—Clonidine—glaucoma	0.000763	0.00229	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—PAX6—glaucoma	0.000757	0.00144	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—FN1—glaucoma	0.000748	0.00142	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—OPN4—glaucoma	0.000739	0.00141	CbGpPWpGaD
Tirofiban—Dizziness—Betaxolol—glaucoma	0.000739	0.00222	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—TGFB2—glaucoma	0.000731	0.00139	CbGpPWpGaD
Tirofiban—Urticaria—Timolol—glaucoma	0.000726	0.00218	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—VEGFA—glaucoma	0.000722	0.00137	CbGpPWpGaD
Tirofiban—Body temperature increased—Timolol—glaucoma	0.000722	0.00217	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—SOD1—glaucoma	0.000719	0.00137	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—MMP2—glaucoma	0.000714	0.00136	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—MMP1—glaucoma	0.000711	0.00135	CbGpPWpGaD
Tirofiban—Headache—Betaxolol—glaucoma	0.0007	0.00211	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—HEYL—glaucoma	0.000687	0.00131	CbGpPWpGaD
Tirofiban—Hypersensitivity—Timolol—glaucoma	0.000673	0.00202	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—PTGFR—glaucoma	0.000666	0.00127	CbGpPWpGaD
Tirofiban—Nausea—Betaxolol—glaucoma	0.000664	0.002	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—FN1—glaucoma	0.000649	0.00124	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—VEGFA—glaucoma	0.000627	0.00119	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—MMP2—glaucoma	0.000606	0.00115	CbGpPWpGaD
Tirofiban—Dizziness—Timolol—glaucoma	0.000604	0.00182	CcSEcCtD
Tirofiban—Headache—Timolol—glaucoma	0.000572	0.00172	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—OPN4—glaucoma	0.000569	0.00108	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—VEGFA—glaucoma	0.000556	0.00106	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—SOD1—glaucoma	0.000554	0.00105	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—MMP2—glaucoma	0.00055	0.00105	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—MMP1—glaucoma	0.000549	0.00104	CbGpPWpGaD
Tirofiban—Nausea—Timolol—glaucoma	0.000542	0.00163	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—MMP9—glaucoma	0.000537	0.00102	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HEYL—glaucoma	0.000529	0.00101	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—CAV1—glaucoma	0.000526	0.001	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RPTOR—glaucoma	0.000521	0.000991	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTGFR—glaucoma	0.000513	0.000976	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NCK2—glaucoma	0.000504	0.00096	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—FN1—glaucoma	0.000501	0.000953	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TP53—glaucoma	0.000489	0.00093	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—VEGFA—glaucoma	0.000483	0.00092	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MMP2—glaucoma	0.000467	0.000889	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—MMP9—glaucoma	0.000456	0.000867	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MMP2—glaucoma	0.000433	0.000824	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HDAC9—glaucoma	0.000429	0.000816	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—VEGFA—glaucoma	0.000428	0.000815	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—MMP1—glaucoma	0.000423	0.000804	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—MMP9—glaucoma	0.000414	0.000787	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—VEGFA—glaucoma	0.000409	0.000779	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—CAV1—glaucoma	0.000405	0.000771	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RPTOR—glaucoma	0.000401	0.000764	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—NOS3—glaucoma	0.000398	0.000757	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NCK2—glaucoma	0.000389	0.00074	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—FN1—glaucoma	0.000386	0.000734	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MMP9—glaucoma	0.000351	0.000668	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SMO—glaucoma	0.000336	0.000639	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MMP2—glaucoma	0.000333	0.000634	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HDAC9—glaucoma	0.00033	0.000629	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MMP9—glaucoma	0.000325	0.000619	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—VEGFA—glaucoma	0.000315	0.0006	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NTRK2—glaucoma	0.000307	0.000584	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—NOS3—glaucoma	0.000306	0.000583	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—VEGFA—glaucoma	0.000292	0.000556	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—VEGFA—glaucoma	0.000287	0.000545	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NGFR—glaucoma	0.000263	0.000501	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SMO—glaucoma	0.000259	0.000492	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MMP9—glaucoma	0.000251	0.000477	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TNF—glaucoma	0.00025	0.000476	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NTRK1—glaucoma	0.00025	0.000476	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NTRK2—glaucoma	0.000236	0.00045	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN2B—glaucoma	0.000231	0.000439	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—VEGFA—glaucoma	0.000225	0.000428	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EDN1—glaucoma	0.000221	0.000421	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—VEGFA—glaucoma	0.000221	0.00042	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TP53—glaucoma	0.000216	0.000412	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NGF—glaucoma	0.000203	0.000387	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NGFR—glaucoma	0.000203	0.000386	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—C3—glaucoma	0.000193	0.000368	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TNF—glaucoma	0.000193	0.000367	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NTRK1—glaucoma	0.000193	0.000367	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—APOE—glaucoma	0.00018	0.000342	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CAV1—glaucoma	0.000178	0.000339	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN2B—glaucoma	0.000178	0.000338	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EDN1—glaucoma	0.00017	0.000324	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FN1—glaucoma	0.00017	0.000323	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—BAD—glaucoma	0.000168	0.000319	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TP53—glaucoma	0.000167	0.000317	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NGF—glaucoma	0.000157	0.000298	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—C3—glaucoma	0.000149	0.000283	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—APOE—glaucoma	0.000139	0.000264	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CAV1—glaucoma	0.000137	0.000261	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NOS3—glaucoma	0.000135	0.000257	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FN1—glaucoma	0.000131	0.000249	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—BAD—glaucoma	0.000129	0.000246	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN1B—glaucoma	0.000117	0.000222	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MMP9—glaucoma	0.000108	0.000206	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NOS3—glaucoma	0.000104	0.000198	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—VEGFA—glaucoma	9.71e-05	0.000185	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN1B—glaucoma	9e-05	0.000171	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MMP9—glaucoma	8.33e-05	0.000159	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—VEGFA—glaucoma	7.48e-05	0.000142	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TP53—glaucoma	7.34e-05	0.00014	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TP53—glaucoma	5.65e-05	0.000108	CbGpPWpGaD
